Author

Klara Klein

Primary ORCID profile (0009-0008-1754-3315 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Klara KleiniD2 papers

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Eric S. Lander· 1 shared Marcus Altfeld· 1 shared Tim Wang· 1 shared Wilfredo F. Garcia-Beltran· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Eric S. Lander

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJan 27, 2019

Applying CRISPR-based genetic screens to identify drivers of tumor-cell sensitivity towards NK-cell attack

Klara Klein, Tim Wang, Eric S. Lander…·Wilfredo F. Garcia-Beltran

This study uses CRISPR-based screens to identify factors that enhance NK-cell cytotoxicity against tumor cells, finding B7H6 as a key ligand for NKp30.

DOI 10.1101/531962

humangenetic perturbation / CRISPR

𝕏 PostBluesky